¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Epithelial membrane antigen"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º
  • chorioallantoic membrane
    À¶¸ð¸·¿ä¸·
  • drum membrane
    °í¸·
  • definitive fetal membrane
    ¿Ï¼ºÅ¾Ƹ·, È®Á¤Å¾Ƹ·
  • dentinoenamel membrane
    »ó¾Æ»ç±âÁú¸·
  • Descemet¡¯s membrane
    µ¥½º¸Þ¸·, µÚ°æ°èÆÇ
  • different membrane protein
    À¯°ü¸·´Ü¹éÁú
  • decidual membrane
    Å»¶ô¸·
  • diphtheritic membrane
    µðÇÁÅ׸®¾Æ¸·
  • excitable membrane
    ÈïºÐ¸·
  • exocoelomic membrane
    ü°­¹Û¸·, ü°­¿Ü¸·
  • extracorporeal membrane oxygenation
    ü¿Ü¸·»ê¼Ò°ø±Þ
  • extracorporeal membrane oxygenator
    ü¿Ü¸·»ê¼Ò°ø±Þ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·
  • arachnoid membrane
    °Å¹Ì¸·
  • atlanto-occipital membrane
    °í¸®µÚÅë¼ö¸·
  • basement membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • buccopharyngeal membrane
    º¼Àεθ·
  • membrane bone
    ¸·»À
  • primary membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • reticulofibrous membrane bone
    (¢¡primary membrane bone) ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º
  • chorioallantoic membrane
    À¶¸ð¸·¿ä¸·
  • choriocapillary membrane
    ¸Æ¶ô¸·¸ð¼¼Ç÷°üÃþ
  • cloacal membrane
    ¹è¼³°­¸·
  • cricothyroid membrane
    ¹ÝÁö¹æÆÐ¸·
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • D antigen
    DÇ׿ø
  • D-related antigen
    D-°ü·ÃÇ׿ø
  • DP antigen
    DPÇ׿ø
  • DQ antigen
    DQÇ׿ø
  • DR antigen
    DRÇ׿ø
  • Diego antigen
    µð¿¡°íÇ׿ø
  • EB nuclear antigen(EBNA0
    EB ¹ÙÀÌ·¯½º ÇÙÇ׿ø
  • EB nuclear antigen (EBNA)
    EB¹ÙÀÌ·¯½º ÇÙÇ׿ø
  • EBV capsid antigen
    EB¹ÙÀÌ·¯½º ĸ½Ãµå Ç׿ø
  • EBV capsid antigen (VCA)
    EB¹ÙÀÌ·¯½º ĸ½ÃµåÇ׿ø
  • Forssman antigen
    Æ÷½º¸¸Ç׿ø
  • Fy antigen/antibody
    Fy Ç׿ø/Ç×ü
  • Gag => group specifiic antigen/core
    ±×·ì<±º>ƯÀ̼º Ç׿ø/ÄÚ¾î
  • Gag antigen in HIV infection
    HIV °¨¿°ÀÇ gag Ç׿ø
  • Gag antigen:
    gag Ç׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antigen tolerance
    Ç׿ø°ü¿ë.
  • antigen unit
    Ç׿ø´ÜÀ§.
  • antigen variation
    Ç׿øº¯ÀÌ.
  • antigen, Australia
    ¿À½ºÆ®·¹Àϸ®¾ÆÇ׿ø, BÇü °£¿°¹ÙÀÌ·¯½º
  • antigen, Boivins
    º¸À̺óÇ׿ø
  • antigen, D-related
    D-°ü·ÃÇ׿ø
  • antigen, Forssmans
    Æ÷½º¸¸Ç׿ø
  • antigen, H
    HÇ׿ø, Æí¸ðÇ׿ø
  • antigen, H-2 (histocompatibility)
    H-2 Ç׿ø (Á¶Á÷ÀûÇÕÇ׿øÀÇ)
  • antigen, H-Y
    H-Y Ç׿ø
  • antigen, I region-associated
    Ir¿¬°üÇ׿ø
  • antigen, Ia
    IaÇ׿ø
  • antigen, Leu
    LeuÇ׿ø
  • antigen, Qa
    QaÇ׿ø (H-2º¹ÇÕüÀÇ)
  • antigen, Rh
    RhÇ׿ø
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Oropharyngeal membrane
    ÀÔÀεθ·
    [¿¾ ¿ë¾î] ±¸°­Àεθ·
  • Oropharyngeal[Buccopharyngeal] membrane
    ÀÔÀεθ·
    [¿¾ ¿ë¾î] ±¸°­Àεθ·
  • Oronasal membrane
    ÀÔÄÚ»çÀ̸·
    [¿¾ ¿ë¾î] ±¸ºñ¸·
  • Plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÇüÁú¸·
  • Mucous membrane
    Á¡¸·Ãþ
    [¿¾ ¿ë¾î] Á¡¸·
  • Crural interosseous membrane
    Á¾¾Æ¸®»À»çÀ̸·
    [¿¾ ¿ë¾î] ÇÏÅð°ñ°£¸·
  • Interosseous membrane
    Á¾¾Æ¸®»À»çÀ̸·
    [¿¾ ¿ë¾î] ÇÏÅð°ñ°£¸·
  • Fenestrated elastic membrane
    ⟷¸·
    [¿¾ ¿ë¾î] À¯Ã¢Åº·Â¸·
  • Fenestrated elastic membrane
    ⟷¸·
    [¿¾ ¿ë¾î] ź·ÂÀ¯Ã¢¸·
  • Acrosomal membrane
    ÷´Üü¸·
    [¿¾ ¿ë¾î] ÷´Üü¸·
  • First pharyngeal membrane
    ù°Àεθ·
    [¿¾ ¿ë¾î] Á¦ÀÏÀεθ·
  • Exocoelomic membrane
    ü°­¹Û¸·
    [¿¾ ¿ë¾î] ¿Üü°­¸·
  • Periodontal membrane
    Ä¡¾Æ»Ñ¸®¸·
    [¿¾ ¿ë¾î] -
  • Elastic cone [Cricovocal membrane]
    ź·Â¿ø»Ô [¹ÝÁö¼º´ë¸·]
    [¿¾ ¿ë¾î] ź¼º¿øÃß
  • Defect of fetal membrane
    žƸ·°áÇÔ
    [¿¾ ¿ë¾î] Ÿ·°áÇÔ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
EP echo planar; ectopic pregnancy; edible portion; electrophoresis; electrophysiologic; electroprecipit...
EPI echo planar imaging; electronic portal imaging; Emotion Profile Index; epilepsy; epinephrine; epithe...
ep's epithelial cells
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
FEH focal epithelial hyperplasia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GVEC Glomerular visceral epithelial cell
HTE Hamster trachea epithelial
HBE Human bronchial epithelial
HBEC human bronchial epithelial cell
HCE Human corneal epithelial
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cloacal membrane
    ¹è¼³°­ ¸·, ÃÑ ¹è¼³°­ ¸·
  • decidual membrane
    Å»¶ô¸·
  • demarcation membrane
    ºÐ°è ¸·
  • descemets membrane
    µ¥½º¸Þ ¸·
  • excitable membrane
    ÈïºÐ ¸·
  • false membrane
    °¡¸·, À§¸·
  • fertilization membrane
    ¼öÁ¤¸·
    ¾ËÀÌ ¼öÁ¤ÇÑ ÈÄ ¾Ë ÁÖÀ§¿¡ Çü¼ºµÇ´Â ¸·. ¿¹¸¦ µé¸é, ¼º°Ô³ª ºÒ°¡»ç¸®ÀÇ °æ¿ì´Â ¹Ì¼öÁ¤¶õÀº ±× Ç¥¸é¿¡ ¹ÐÂøµÈ ¸Å¿ì ¾ã°í ¿¬ÇÑ ³­¸·À» °¡Áö°í ÀÖ´Ù°¡ ¼öÁ¤À» ÇÒ ¶§´Â ÀÌ ³­¸·ÀÌ Ç¥¸éÀ¸·ÎºÎÅÍ ºÐ¸®ÇÏ¿© ´Ü´ÜÇÏ°í Æ°Æ°ÇÑ ¸·À¸·Î º¯ÇÑ´Ù. À̰ÍÀÌ ¼öÁ¤¸·ÀÌ´Ù. À̰ÍÀº ¾ËÀÌ ¹ß»ý Ãʱâ, Áï ³­ÇÒ¿¡¼­ Æ÷¹è±â ¶§±îÁö ¾ËÀ» º¸È£Çϰųª, °¢ ¼¼Æ÷°¡ »óÈ£ À§Ä¡¸¦ À¯ÁöÇÏ´Â µ¥ µµ¿òÀ» ÁØ´Ù. ¼º°ÔÀÇ °æ¿ì ¹ß»ýÀÌ ÁøÇàµÇ¾î Æ÷¹è±â Á¤µµ¿¡¼­ ºÐºñÇÑ ºÎÈ­ È¿¼Ò°¡ ¼öÁ¤¸·À» ³ì¿© À¯»ýÀÌ ¹Ù´å¼ÓÀ¸·Î Çì¾öÃÄ ³ª°¥ ¼ö ÀÖ°Ô ÇÑ´Ù. ¼öÁ¤¸·°ú ¾Ë Ç¥¸é »çÀÌÀÇ À§¶õ°­¿¡ ÄÝ·ÎÀ̵å»ó ¹°ÁúÀÌ µé¾î ÀÖ´Ù.
  • fibrous membrane
    ¼¶À¯ ¸·
  • human fetal membrane
    »ç¶÷ ÅÂ¾Æ ¸·
  • hyaline membrane disease
    À¯¸®Áú¸·º´
    ¹Ì¼÷¾Æ¿¡¼­ Ãâ»ý Á÷ÈÄ ¹ß»ýÇÏ´Â °¡Àå ÈçÇÑ Áúº´ Áß Çϳª·Î¼­ ½Å»ý¾Æ »ç¸ÁÀÇ Áß¿ä ¿øÀÎÁß ÇϳªÀÌ´Ù.
  • Jacob's membrane
    ÀçÄß ¸·
    ¸Á¸·ÀÇ °£»óÃþ ¹× ÁÖüÃþÀÇ ¼¼Æ÷Ãþ ¸·.
  • line of periodontal membrane
    Ä¡±Ù¸· ¼±
  • lining membrane
    ³»¸·
    ¼¼Æ÷¸·Àº ÁöÁú ÀÌÁß Ãþ ±¸Á¶·Î µÇ¾î ÀÖ°í ±× Áß ¾È ÂÊÀÇ ¸·, ¼¼Æ÷ ÀÚü¸¦ µ¤¾î º¸È£Çϰí ÀÖ´Ù. ¶ÇÇÑ »êÈ­ ÀÛ¿ë¿¡ ÀÇÇØ »ý±ä ±Ý¼ÓÀÇ »êÈ­ ¸·À» ÀÌ·¸°Ô Ç¥ÇöÇϱ⵵ ÇÑ´Ù.
  • membrane labilizer
    ¸· ºÒ¾ÈÁ¤ ¾à, ¸· ºÒ¾ÈÁ¤È­ ¾à
  • membrane protein
    ¸· ´Ü¹éÁú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
proliferating cell nuclear antigen Acidic nuclear protein (33 kD) highly expressed in dividing cells. Interacts with D type cyclins.
(18 Nov 1997)
hepatitis-associated antigen A term used for the surface antigen of hepatitis B virus before its nature was established.
See: hepatitis B surface antigen.
(05 Mar 2000)
hepatitis B antigen Antigens of the virion of the hepatitis b virus or the dane particle, its surface, core and other associated antigens, like the hbe antigen.
(12 Dec 1998)
hepatitis B core antigen <virology> (HBcAb, HBcAg), the antigen found in the core of the Dane particle (which is the complete virus) and also in hepatocyte nuclei in hepatitis B infections.
(05 Mar 2000)
hepatitis B e antigen (HBeAb, HBe, HBeAg), an antigen, or group of antigen's, associated with hepatitis B infection and distinct from the surface antigen (HBsAg) and the core antigen (HBcAg); it is associated with the viral nucleocapsid. Its presence indicates that the virus is replicating and the individual is potentially infectious.
(05 Mar 2000)
hepatitis B surface antigen <virology> A serologic marker on the surface of the hepatitis B virus. The body will normally produce antibodies to hepatitis B surface antigen as part of the normal immune response to infection. It is the presence of antibodies to the hepatitis B surface antigen that are detected in a positive hepatitis B blood test.
(27 Sep 1997)
prostate-specific antigen <tumour marker> A simple blood test used to detect prostate cancer in men. The test measures a specific antigen normally secreted by the prostate. If cancer is developing, the prostate secretes greater amounts of prostate-specific antigen. This test is recommended for men with an enlarged prostate and an increased risk of prostate cancer.
It is an enzyme that is produced by epithelial cells of both benign and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
It is a single chain 31 kilodalton glycoprotein with 240 amino acid residues and 4 carbohydrate side chains that is a kallikrein protease.
It is found in normal seminal fluid and produced by the prostatic epithelial cells.
Elevated levels in blood serum are associated with prostatic enlargement and prostatic adenocarcinoma, and this allows early detection of cancer in many cases. In about 70% of cases, the rise is due to a cancerous condition.
No large scale clinical studies have been completed to assess the impact of testing on survival from prostate cancer, and the medical and economic value of testing remain uncertain.
Acronym: PSA
Registry number: EC 3.4.21.77
(22 Sep 2002)
heterogeneic antigen An antigen or antigenic determinant which is found in different tissues in more than one species.
(05 Mar 2000)
heterogenetic antigen An antigen which is possessed by a variety of different phylogenetically unrelated species; e.g., the various organ-or tissue-specific antigen's, the alpha-and beta-crystalline protein of the lens of the eye, and Forssman antigen.
Synonym: heterophil antigen.
(05 Mar 2000)
heterogenic enterobacterial antigen Cross reacting antigen (epitope), a common antigen that occurs in 2 or more different molecules/organisms.
Synonym: heterogenic enterobacterial antigen.
(05 Mar 2000)
heterophil antigen An antigen which is possessed by a variety of different phylogenetically unrelated species; e.g., the various organ-or tissue-specific antigen's, the alpha-and beta-crystalline protein of the lens of the eye, and Forssman antigen.
Synonym: heterophil antigen.
(05 Mar 2000)
heterophile antigen An antigen or antigenic determinant which is found in different tissues in more than one species.
(05 Mar 2000)
Xg antigen xg blood group
histocompatibility antigen <immunology> A set of plasmalemmal glycoproteins on the surface of all nucleated cells that are crucial for T-cell recognition of antigens. Particularly the HLA system in humans and the H2 system in mice. They are the major antigens responsible for tissue recognition. For this reason, they are of prime importance in determining compatible organ donors for a specific transplantation procedure. Each person has unique HLA antigens. Some HLA antigens have been identified to be correlated with the presence of certain autoimmune diseases. One of these is the HLA-B27 site. Approximately 85% of patients with ankylosing spondylitis and Reiter's syndrome will have the HLA-B27 antigen present on the leukocytes.
There are two classes of histocompatibility antigens:
1. Class I, histocompatibility antigens composed of two glycosylated subunits, a heavy chain of 44 kD and beta2 microglobulin (12 kD). The heavy chain may be coded by K, D or L genes of mouse H2 and A, B or C genes of human HLA complex. Class I antigens are important in T-cell killing and are recognised in conjunction with the foreign cell surface antigens MHC restriction).
2. Class II antigens, heterodimeric histocompatibility antigens composed of alpha (32 kD) and beta (28 kD) chains. Found mostly on B lymphocytes, macrophages and accessory cells. The response of T helper cells requires that the foreign antigen is presented in conjunction with the appropriate Class II antigens. (Murine H2 Ia antigens and human HLA DR antigens are Class II).
(14 Oct 1997)
HLA-a1 antigen <immunology> Human histocompatibility (HLA) surface antigen encoded by the a locus on chromosome 6. Individuals bearing this allele are more susceptible to hodgkin's disease. HLA-a1 is in linkage disequilibrium with HLA-b8 and HLA-dr3.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á